|
|
Application of cervical injection of Pituitrin and Oxytocin combined with uterine aspiration + hysteroscopy in type Ⅰ-Ⅱscar pregnancy |
DENG Shu-lan |
Department of Gynecology and Obstetrics,Jiangxi Ji′an Maternal and Child Health Hospital,Jiangxi Province,Ji′an 343000,China |
|
|
Abstract Objective To explore the application effect of cervical injection of Pituitrin and Oxytocin combined with uterine aspiration + hysteroscopy in type Ⅰ-Ⅱscar pregnancy. Methods A total of 98 patients with type Ⅰ-Ⅱscar pregnancy who were admitted to our hospital from August 2018 to December 2019 were selected as research subjects.According to the random number table method,the patients were divided into observation group and control group,with 49 cases in each group.The control group was given removal of transvaginal scar pregnancy lesions under epidural anesthesia,and the study group was given cervical injection of Pituitrin and Oxytocin combined with uterine aspiration+ hysteroscopy.The intraoperative blood loss,surgery time,negative conversion time of blood human chorionic gonadotropin (HCG),length of hospital stay,hospitalization cost and complications were compared between the two groups. Results The intraoperative blood loss in the observation group was less than that in the control group,the surgery time and the negative conversion time of blood HCG were shorter than those in the control group,the differences were statistically significant (P<0.05).The length of hospital stay in the observation group was shorter than that in the control group,and the hospitalization cost was less than that in the control group,the differences were statistically significant (P<0.05).The total incidence rate of complications in the observation group was 4.08%,which was lower than 16.33% in the control group,and the difference was statistically significant (P<0.05).Conclusion Cervical injection of Pituitrin and Oxytocin combined with uterine aspiration + hysteroscopy in the treatment of type Ⅰ-Ⅱscar pregnancy has a significant effect,which can shorten the treatment time and reduce bleeding,and there is no surgical incision and fewer complications,which is worthy of clinical promotion and application.
|
|
|
|
|
[1] |
谢幸,孔北华,段涛.妇产科学[M].9 版.北京:人民卫生出版社,2018:80.
|
[2] |
张科花.经阴道超声对子宫瘢痕妊娠的诊断价值研究[J].实用医学影像杂志,2019,20(3):317-319.
|
[3] |
邢海燕.剖宫产术后子宫瘢痕妊娠的诊断与治疗[J].中国妇幼保健,2008,23(22):28-30.
|
[4] |
郭艳嫦,严燕琼,雷伟玲,等.经阴道彩色多普勒超声对Ⅰ型及Ⅱ型子宫瘢痕妊娠的诊断价值[J].分子影像学杂志,2019,42(3):306-309.
|
[5] |
何卫华.子宫动脉栓塞术联合清宫术治疗剖宫产术后子宫瘢痕妊娠体会[J].河南外科学杂志,2018,24(4):136-137.
|
[6] |
史美华.子宫动脉栓塞术在剖宫产子宫瘢痕部位妊娠中的应用效果[J].中国民康医学,2019,31(13):57-59.
|
[7] |
王伟丽.垂体后叶素与催产素治疗瘢痕子宫妊娠人流术大出血患者80 例[J].河南医学高等专科学校学报,2018,30(3):260-261.
|
[8] |
胡春兰,邓亚丽.Foley 尿管联合垂体后叶素在Ⅰ型剖宫产瘢痕妊娠清宫术中的临床疗效[J].湘南学院学报(医学版),2015,17(2):34-35.
|
[9] |
中华医学会妇产科学分会计划生育学组.剖宫产术后子宫瘢痕妊娠诊治专家共识(2016)[J].中华妇产科杂志,2016,51(8):568-572.
|
[10] |
康丽荣,张林爱.剖宫产术后子宫切口瘢痕妊娠40 例回顾性分析[J].中国药物与临床,2019,19(5):768-771.
|
[11] |
肖颜丹.彩色多普勒超声诊断子宫峡部剖宫产瘢痕妊娠的价值[J].中外医学研究,2018,16(17):66-67.
|
[12] |
周欣,肖菊花.子宫瘢痕妊娠的发病机制及诊治进展[J].中国临床新医学,2019,12(8):837-841.
|
[13] |
安瑞,李长东.剖宫产瘢痕妊娠发病机制及影响因素[J].中国计划生育学杂志,2018,26(7):643-646.
|
[14] |
王文清.米非司酮配伍米索前列醇联合B 超监视下清宫术治疗子宫瘢痕妊娠的效果观察[J].泰山医学院学报,2018,39(6):604-606.
|
[15] |
蒋晓辉.子宫动脉栓塞术治疗子宫瘢痕妊娠的效果分析[J].临床医学工程,2019,26(3):343-344.
|
[16] |
吴菁,孙莹,晋一超,等.垂体后叶素联合宫腔镜下清宫术治疗Ⅰ型剖宫产瘢痕妊娠[J].南京医科大学学报,2019,39(2):242-246.
|
[17] |
刘宝玲.宫腔镜联合垂体后叶素治疗剖宫产切口妊娠的临床效果观察[J].现代医学与健康研究电子杂志,2018,2(11):42.
|
[18] |
罗秀清,罗胜勇.宫腔镜检查异常子宫出血168 例临床分析[J].安徽医学,2018,39(12):1487-1489.
|
|
|
|